Literature DB >> 32266090

The systems of metastatic potential prediction in pheochromocytoma and paraganglioma.

Yong Wang1, Minghao Li1, Hao Deng1, Yingxian Pang1, Longfei Liu1,2, Xiao Guan1,2.   

Abstract

Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors that arising from the adrenal medulla or extra-adrenal autonomic ganglia. Traditionally, PPGL was classified as benign or malignant based on the presence of distant metastasis at the time of initial surgery. However, according to WHO 2017 Classification of Tumors of Endocrine Organs, all PPGL has metastatic potential. The term "metastatic" is used, replacing "malignant" in this group of tumors. The prediction of PPGL's metastatic potential is a clinical concern, although many relevant indicators such as genetics, histology, pathology and molecular biology markers have been proved to be related to the metastasis of PPGL, but none of them is 100% predictive; various types of prediction systems had been created, but previous studies had demonstrated that they still need to be validated in multicenter studies. There is no unified clinical standard to differentiate metastatic from non-metastatic and a highly effective prediction system is of urgent need. In this review, we summarized all reported prediction systems, including the PASS system, the GAPP system, the COPPs system and the ASES system. Additional potential indicators that related to metastatic PPGL were also introduced. AJCR
Copyright © 2020.

Entities:  

Keywords:  PPGL; Pheochromocytoma; metastatic potential; paraganglioma; prediction systems

Year:  2020        PMID: 32266090      PMCID: PMC7136918     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  63 in total

Review 1.  PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.

Authors:  Leilani B Mercado-Asis; Katherine I Wolf; Ivana Jochmanova; David Taïeb
Journal:  Endocr Pract       Date:  2017-11-16       Impact factor: 3.443

2.  The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Authors:  E Patterson; R Webb; A Weisbrod; B Bian; M He; L Zhang; A K Holloway; R Krishna; N Nilubol; K Pacak; E Kebebew
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

3.  MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.

Authors:  Samantha M Ruff; Reed I Ayabe; Parisa Malekzadeh; Meghan L Good; Michael M Wach; Melissa K Gonzales; Amit Tirosh; Naris Nilubol; Karel Pacak; Electron Kebebew; Dhaval Patel
Journal:  J Surg Res       Date:  2019-05-27       Impact factor: 2.192

Review 4.  Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.

Authors:  Jenny Welander; Peter Söderkvist; Oliver Gimm
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

5.  Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.

Authors:  Judith Goncalves; Charlotte Lussey-Lepoutre; Judith Favier; Anne-Paule Gimenez-Roqueplo; Luis Jaime Castro-Vega
Journal:  Ann Endocrinol (Paris)       Date:  2019-04-11       Impact factor: 2.478

Review 6.  Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.

Authors:  Veronica K Y Cheung; Anthony J Gill; Angela Chou
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

7.  Von Hippel-Lindau "Black Forest" mutation inherited in a large Chinese family.

Authors:  Peihua Liu; Feizhou Zhu; Minghao Li; Daud Athanasius Dube; Qianqian Liu; Cikui Wang; Qiao Xiao; Liang Zhang; Shuai Gao; Zhuolin Li; Bo Zhang; Jing Liu; Longfei Liu; Xiang Chen
Journal:  Gland Surg       Date:  2019-08

8.  Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.

Authors:  Travers Ching; Karolina Peplowska; Sijia Huang; Xun Zhu; Yi Shen; Janos Molnar; Herbert Yu; Maarit Tiirikainen; Ben Fogelgren; Rong Fan; Lana X Garmire
Journal:  EBioMedicine       Date:  2016-03-19       Impact factor: 8.143

9.  Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.

Authors:  Kyong Young Kim; Jung Hee Kim; A Ram Hong; Moon-Woo Seong; Kyu Eun Lee; Su-Jin Kim; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

Review 10.  The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature.

Authors:  Adam Stenman; Jan Zedenius; Carl Christofer Juhlin
Journal:  Cancers (Basel)       Date:  2019-02-15       Impact factor: 6.639

View more
  11 in total

1.  Sclerosing Paragangliomas: Correlations of Histological Features with Patients' Genotype and Vesicular Monoamine Transporter Expression.

Authors:  Angela Pucci; Alessandra Bacca; Ivana Barravecchia; Iosè Di Stefano; Beatrice Belgio; Daniele Lorenzini; Liborio Torregrossa; Serena Chiacchio; Caterina Congregati; Gabriele Materazzi; Mauro Ferrari; Debora Angeloni; Giampaolo Bernini; Fulvio Basolo
Journal:  Head Neck Pathol       Date:  2022-05-07

2.  Peripancreatic paraganglioma: Lesson from a round table.

Authors:  Federica Petrelli; Geri Fratini; Andrea Sbrozzi-Vanni; Andrea Giusti; Raffele Manta; Claudio Vignali; Gabriella Nesi; Andrea Amorosi; Andrea Cavazzana; Marco Arganini; Maria Raffaella Ambrosio
Journal:  World J Gastroenterol       Date:  2022-06-07       Impact factor: 5.374

3.  Value of Immunohistochemical Expression of Apelin, Succinate Dehydrogenase B, Chromogranin B, Human Epidermal Growth Factor Receptor-2, Contactin 4, and Succinyl-CoA Synthetase Subunit Beta in Differentiating Metastatic From Non-Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Yong Wang; Danlei Chen; Yingxian Pang; Xiaowen Xu; Xiao Guan; Longfei Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

4.  Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.

Authors:  Eu Jeong Ku; Kyoung Jin Kim; Jung Hee Kim; Mi Kyung Kim; Chang Ho Ahn; Kyung Ae Lee; Seung Hun Lee; You-Bin Lee; Kyeong Hye Park; Yun Mi Choi; Namki Hong; A Ram Hong; Sang-Wook Kang; Byung Kwan Park; Moon-Woo Seong; Myungshin Kim; Kyeong Cheon Jung; Chan Kwon Jung; Young Seok Cho; Jin Chul Paeng; Jae Hyeon Kim; Ohk-Hyun Ryu; Yumie Rhee; Chong Hwa Kim; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06

5.  Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion.

Authors:  Minghao Li; Christina Pamporaki; Stephanie M J Fliedner; Henri J L M Timmers; Svenja Nölting; Felix Beuschlein; Aleksander Prejbisz; Hanna Remde; Mercedes Robledo; Stefan R Bornstein; Jacques W M Lenders; Graeme Eisenhofer; Nicole Bechmann
Journal:  Discov Oncol       Date:  2021-03-19

Review 6.  Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.

Authors:  Balazs Sarkadi; Eva Saskoi; Henriett Butz; Attila Patocs
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

7.  Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience.

Authors:  Liang Zhang; Danlei Chen; Yingxian Pang; Xiao Guan; Xiaowen Xu; Cikui Wang; Qiao Xiao; Longfei Liu
Journal:  Asian J Urol       Date:  2022-06-20

Review 8.  Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.

Authors:  Yuto Yamazaki; Xin Gao; Alessio Pecori; Yasuhiro Nakamura; Yuta Tezuka; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Fumitoshi Satoh; Hironobu Sasano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-27       Impact factor: 5.555

Review 9.  A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors.

Authors:  Marina Tsoli; Kosmas Daskalakis; Eva Kassi; Gregory Kaltsas; Apostolos V Tsolakis
Journal:  Biology (Basel)       Date:  2021-06-25

10.  Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.

Authors:  Heather Wachtel; Troy Hutchens; Ezra Baraban; Lauren E Schwartz; Kathleen Montone; Zubair Baloch; Virginia LiVolsi; Lauren Krumeich; Douglas L Fraker; Katherine L Nathanson; Debbie L Cohen; Lauren Fishbein
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.